Sunkaria A
Guru Nanak Dev University, National Institute of Pharmaceutical Education and Research Ahmedabad, Panjab University, Post Graduate Institute of Medical Education and Research
0000-0001-7251-3436
About
I am Dr. Aditya Sunkaria, currently serving as a faculty member in the Department of Biotechnology at Guru Nanak Dev University, Amritsar, India. My research primarily focuses on understanding the molecular mechanisms underlying neurodegenerative diseases, with a specific emphasis on Alzheimer’s disease. I am deeply invested in exploring the roles of proteomics, mitochondrial dysfunction, oxidative stress, and microRNAs in the progression of neurodegenerative disorders.
Over the years, I have worked on identifying early biomarkers for Alzheimer's disease and have contributed to unveiling novel therapeutic targets and interventions. My work also extends to investigating the relationship between metabolic disorders, such as diabetes, and cognitive dysfunction. I am particularly interested in the therapeutic potential of natural compounds and their impact on neuroprotection and healthy aging.
My research aims to bridge the gap between basic neuroscience and translational medicine by identifying novel targets for disease intervention and early diagnostic tools. I am passionate about contributing to advancements in therapeutic strategies for managing neurodegenerative and metabolic disorders, helping pave the way for innovative treatments and improved patient outcomes.
Employment
-
Guru Nanak Dev University Assistant Professor2019 - Present
-
National Institute of Pharmaceutical Education and Research Ahmedabad Assistant Professor2017 - 2019
Education
-
Panjab University Dr. DS Kothari Postdoc Fellowship2013 - 2015
-
Post Graduate Institute of Medical Education and Research PhD2008 - 2013
-
Guru Nanak Dev University MS2005 - 2007
-
Guru Nanak Dev University BS2002 - 2005
Projects & Funding
Projects & funding information is unavailable.
Publications (49)
- Orexin-A and Circadian Disruption in Alzheimer’s Disease: Implications for Amyloid-Beta Pathology Save
- The mitochondria-synapse axis in Alzheimer’s disease: Lost coordination in early stages Save
- Unlocking the therapeutic promise of miRNAs in promoting amyloid-β clearance for Alzheimer's disease Save
- From Plant to Pathway: Molecular Mechanisms of Ruscogenin in Preventing Amyloid-Beta Aggregation through Computational and Experimental Approaches Save
- Machine Learning–Based Bioactivity Prediction and Descriptor-Guided Rational Design of Amyloid-β Aggregation Inhibitors Save
- Proteomic insights into early-stage Alzheimer’s disease: Identifying key neuronal proteins impacted by amyloid beta oligomers in an in vitro model Save
- The hidden players: Shedding light on the significance of post-translational modifications and miRNAs in Alzheimer's disease development Save
- Sleep Disturbance and Alzheimer’s Disease: The Glial Connection Save
- Dietary Supplementation With Tinospora cordifolia Improves Anxiety-Type Behavior and Cognitive Impairments in Middle-Aged Acyclic Female Rats Save
- Dietary intervention with Tinospora cordifolia improved aging-related decline in locomotor coordination and cerebellar cell survival and plasticity in female rats Save